Abiopharma

New Form 8-K - Predictive Oncology Inc. Filed: 2025-06-06 AccNo: 0001171843-25-003768 Size: 250 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 4 - STERIS plc Filed: 2025-06-06 AccNo: 0001628280-25-030024 Size: 5 KB

New Form 8-K - Sarepta Therapeutics, Inc. Filed: 2025-06-06 AccNo: 0000950170-25-083131 Size: 223 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and …

New Form 8-K - OWENS & MINOR INC/VA/ Filed: 2025-06-06 AccNo: 0001193125-25-137107 Size: 150 KB Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement

New Form 8-K - Fortive Corp Filed: 2025-06-06 AccNo: 0001104659-25-057363 Size: 267 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits

New Form 4 - STERIS plc Filed: 2025-06-06 AccNo: 0001628280-25-030023 Size: 10 KB

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

New Form 8-K - MoonLake Immunotherapeutics Filed: 2025-06-06 AccNo: 0001213900-25-052140 Size: 198 KB Item 5.07: Submission of Matters to a Vote of Security Holders

New Form 8-K - NEKTAR THERAPEUTICS Filed: 2025-06-06 AccNo: 0001213900-25-052141 Size: 223 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits

New Form 8-K - Orgenesis Inc. Filed: 2025-06-06 AccNo: 0001641172-25-014075 Size: 201 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item 9.01: Financial Statements and Exhibits

New Form 8-K - Celularity Inc Filed: 2025-06-06 AccNo: 0001641172-25-014073 Size: 252 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

New Form 4 - Tourmaline Bio, Inc. Filed: 2025-06-06 AccNo: 0001827506-25-000074 Size: 5 KB

New Form 4 - IO Biotech, Inc. Filed: 2025-06-06 AccNo: 0000905148-25-002033 Size: 5 KB